FDA.reportPublic FDA data

Sweet Balm

Manufacturer
isamogu Inc.
Effective date
2022-05-02
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:02:09

Label at a glance#

ProductSweet Balm
Active ingredientPEPPERMINT OIL
Label structure11 sections

Dosage and administration

Adults and children 6 months and over. Apply to right below the nostrils. Allow to dry without wiping.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Peppermint Oil 0.65%

Purpose

OTC - PURPOSE SECTION

nasal decongestion

Use

INDICATIONS & USAGE SECTION

Temporary relief of nasal congestion.

Warnings

OTC - DO NOT USE SECTION

Do not use in or near the wounded areas.

Warnings

OTC - WHEN USING SECTION

When using this product do not use in or near the eyes.

Warnings

OTC - STOP USE SECTION

Stop use and ask a doctor if irritation or rash appears and lasts.

Warnings

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Warnings

WARNINGS SECTION

In case of contact, rinse eyes thoroughly with water.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 6 months and over.

Apply to right below the nostrils.

Allow to dry without wiping.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Prunus AmygdalusDulcis (Sweet Almond) Oil, Butyrospermum Parkii (Shea) Butter, Beeswax, Eucalyptus Globulus Leaf Oil, Tocophery Acetate, Limonene, Linalool, Camellia Japonica Seed Oil, Cocos Nucifera (Coconut) Oil, Glyceryl Caprylate, Helianthus Annuus (Sunflower) Seed Oil, Limnanthes Alba (Meadowfoam) Seed Oil, Macadamia Ternifolia Seed Oil, Prunus Armeniaca(Apricot) Kernel Oil, Moringa Oleifera Seed Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Solanum Lycopersicum (Tomato) Seed Oil, Squalane, Vitis vinifera (Grape) seed oil, Chamaecyparis Obtusa Leaf Extract, Ginkgo Biloba Leaf Extract, Butylene Glycol, 1,2-Hexanediol

Sweet Balm Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Sweet Balm_Drug Facts LabelSweet Balm_Drug Facts Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82690-302-012024-07-29C16284748780-11030e365-4b26-111a-e063-dadaa90a10e2Sweet Balm 82690-302
82690-302-012024-01-30C16284748780-11030e365-4b26-111a-e063-dadaa90a10e2Sweet Balm 82690-302

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82690-30282690-302-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Name, UNII, Kind table
NameUNIIKind
CHAMAECYPARIS OBTUSA LEAF7OL154J5XBIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
LINALOOL, (+/-)-D81QY6I88EIACT
APRICOT KERNEL OIL54JB35T06AIACT
PEPPERMINT OILAV092KU4JHACTIB
ALMOND OIL66YXD4DKO9IACT
SHEA BUTTERK49155WL9YIACT
YELLOW WAX2ZA36H0S2VIACT
EUCALYPTUS OIL2R04ONI662IACT
ALPHA-TOCOPHEROL ACETATE9E8X80D2L0IACT
COCONUT OILQ9L0O73W7LIACT
GLYCERYL CAPRYLATETM2TZD4G4AIACT
SUNFLOWER OIL3W1JG795YIIACT
MEADOWFOAM SEED OIL412ZHA4T4YIACT
MACADAMIA OIL515610SU8CIACT
MORINGA OLEIFERA SEED OILREM6A5QMC0IACT
SQUALANEGW89575KF9IACT
GRAPE SEED OIL930MLC8XGGIACT
GINKGO19FUJ2C58TIACT
JOJOBA OIL724GKU717MIACT
TOMATO SEED OIL7N87T9C06TIACT
1,2-HEXANEDIOLTR046Y3K1GIACT
LIMONENE, (+)-GFD7C86Q1WIACT
CAMELLIA JAPONICA SEED OILU37N0S910TIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1e6498ea-b45b-8260-e063-6294a90a4fbbde1330ee-03c0-fdd9-e053-2995a90a17da2024-07-29WarningsExact identifier
spl set id: de1330ee-03c0-fdd9-e053-2995a90a17da

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.